Screening and Treatment of Latent Tuberculosis Among Healthcare Workers at Low, Moderate, and High Risk for Tuberculosis Exposure: A Cost-Effectiveness Analysis
- 1 December 2004
- journal article
- research article
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 25 (12), 1056-1061
- https://doi.org/10.1086/502343
Abstract
Objective:To evaluate cost-effective screening and treatment strategies for healthcare workers (HCWs) at risk for tuberculosis exposure.Design:A Markov model was developed to track three hypothetical cohorts of HCWs at low, moderate, and high risk for tuberculosis exposure. For those found to be tuberculin reactors at entry, the choice was for isoniazid treatment or no treatment. For those without tuberculin reactivity, the choice of screening intervals was 6 months, 1 year, 2 years, or 5 years. Outcomes measured were tuberculosis cases, death, life expectancy, and cost. Assumptions were derived from published data and analyses.Results:Treatment of initial reactors with isoniazid in all three risk groups was associated with a net savings of $14,800 to $15,700 for each tuberculosis case prevented. For those without evidence of infection at entry, the most cost-effective screening interval was 1 year for high-risk groups, 2 years for moderate-risk groups, and 5 years for low-risk groups, with a net savings $0.20 to $26 per HCW per year. Screening at a more frequent interval was still cost-effective.Conclusions:For HCWs found to be tuberculin reactors, treatment of their latent infection is to their benefit and is associated with a net cost-savings. Regular tuberculin screening of HCWs can be cost-effective or result in a net cost-savings. Each institution could use its own skin test surveillance data to create an optimum screening program for its employees. However, for most HCWs, a 1-year screening interval would be a cost-effective and safe choice.Keywords
This publication has 31 references indexed in Scilit:
- Tuberculosis trends in the United States, 1992–2001Tuberculosis, 2003
- Historical risks of tuberculin skin test conversion among non-physician staff at a large urban hospitalAmerican Journal of Industrial Medicine, 2002
- Tuberculin Skin Testing Surveillance of Health Care PersonnelClinical Infectious Diseases, 2002
- Tuberculin Skin Testing of Physicians at a Midwestern Teaching Hospital: A 6-Year Prospective StudyClinical Infectious Diseases, 2001
- Compliance With National Recommendations for Tuberculosis Screening and Immunization of Healthcare Workers in a Children's HospitalInfection Control & Hospital Epidemiology, 2000
- Prevalence of Positive Tuberculin Skin Reactions in a Two-Step Testing Program at a Tertiary-Care Center in Eastern North CarolinaInfection Control & Hospital Epidemiology, 2000
- Mathematical Model for the Epidemiology of Tuberculosis, with Estimates of the Reproductive Number and Infection-Delay FunctionAmerican Journal of Epidemiology, 1998
- Markov Models in Medical Decision MakingMedical Decision Making, 1993
- The Markov Process in Medical PrognosisMedical Decision Making, 1983
- The Epidemiology of Tuberculosis in PhysiciansPublished by American Medical Association (AMA) ,1979